Pier Capital’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-36,491
| Closed | -$4.33M | – | 112 |
|
|
2022
Q1 | $4.33M | Sell |
36,491
-49,411
| -58% | -$5.86M | 0.55% | 85 |
|
|
2021
Q4 | $11.8M | Sell |
85,902
-1,311
| -2% | -$181K | 1.25% | 27 |
|
|
2021
Q3 | $12.1M | Sell |
87,213
-26,705
| -23% | -$3.71M | 1.26% | 22 |
|
|
2021
Q2 | $11.1M | Sell |
113,918
-49,016
| -30% | -$4.76M | 1.11% | 41 |
|
|
2021
Q1 | $11.1M | Buy |
162,934
+96,322
| +145% | +$6.58M | 1.06% | 54 |
|
|
2020
Q4 | $5.71M | Buy |
66,612
+2,117
| +3% | +$181K | 0.6% | 90 |
|
|
2020
Q3 | $4.19M | Sell |
64,495
-813
| -1% | -$52.9K | 0.61% | 91 |
|
|
2020
Q2 | $4.78M | Sell |
65,308
-36,726
| -36% | -$2.69M | 0.76% | 80 |
|
|
2020
Q1 | $3.47M | Buy |
102,034
+35,135
| +53% | +$1.2M | 0.77% | 68 |
|
|
2019
Q4 | $3.64M | Sell |
66,899
-42,026
| -39% | -$2.29M | 0.6% | 87 |
|
|
2019
Q3 | $4.54M | Sell |
108,925
-4,650
| -4% | -$194K | 0.77% | 74 |
|
|
2019
Q2 | $4.97M | Buy |
113,575
+44,786
| +65% | +$1.96M | 0.77% | 78 |
|
|
2019
Q1 | $3.54M | Buy |
+68,789
| New | +$3.54M | 0.55% | 92 |
|